Sana Biotechnology SANA Bothell Washington — Accrued Liabilities And Other Liabilities
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's bothell washington — accrued liabilities and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sana Biotechnology's bothell washington — accrued liabilities and other liabilities?
- Sana Biotechnology (SANA) reported bothell washington — accrued liabilities and other liabilities of $400K in Q1 2026.
- How has Sana Biotechnology's bothell washington — accrued liabilities and other liabilities changed year-over-year?
- Sana Biotechnology's bothell washington — accrued liabilities and other liabilities decreased by 0.0% year-over-year, from $400K to $400K.
- What does bothell washington — accrued liabilities and other liabilities mean?
- Captures the total short-term obligations related to the Bothell facility operations that have been incurred but not yet paid. This includes items such as utilities, maintenance, or other operational expenses specific to this geographic segment. It provides a snapshot of near-term cash outflows required to maintain current facility operations.